MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $321,342 | -98.9% | 7,377 | -98.8% | 0.00% | -100.0% |
| Q4 2022 | $28,869,000 | -71.9% | 637,130 | -56.7% | 0.01% | -73.7% |
| Q3 2022 | $102,650,000 | +4.6% | 1,469,834 | +0.5% | 0.04% | +11.8% |
| Q2 2022 | $98,157,000 | -19.3% | 1,461,986 | -1.1% | 0.03% | -5.6% |
| Q1 2022 | $121,559,000 | -43.7% | 1,478,453 | +0.4% | 0.04% | -40.0% |
| Q4 2021 | $215,961,000 | -23.0% | 1,472,606 | -7.1% | 0.06% | -33.3% |
| Q3 2021 | $280,337,000 | +315.8% | 1,584,999 | +279.8% | 0.09% | +328.6% |
| Q2 2021 | $67,415,000 | +30.1% | 417,352 | +37.9% | 0.02% | +23.5% |
| Q1 2021 | $51,835,000 | -22.7% | 302,642 | -0.9% | 0.02% | -29.2% |
| Q4 2020 | $67,051,000 | -10.9% | 305,276 | -32.7% | 0.02% | -22.6% |
| Q3 2020 | $75,273,000 | +32.1% | 453,437 | -9.2% | 0.03% | +29.2% |
| Q2 2020 | $56,981,000 | +328.9% | 499,107 | +188.8% | 0.02% | +242.9% |
| Q1 2020 | $13,284,000 | +13.7% | 172,832 | +90.7% | 0.01% | +40.0% |
| Q4 2019 | $11,686,000 | +21.6% | 90,624 | -26.6% | 0.01% | +25.0% |
| Q3 2019 | $9,612,000 | -36.8% | 123,444 | -16.3% | 0.00% | -42.9% |
| Q2 2019 | $15,197,000 | +35.6% | 147,567 | -3.5% | 0.01% | +40.0% |
| Q1 2019 | $11,206,000 | +28.8% | 152,937 | -25.5% | 0.01% | +25.0% |
| Q4 2018 | $8,703,000 | +33.0% | 205,282 | +48.4% | 0.00% | +100.0% |
| Q3 2018 | $6,542,000 | +373.4% | 138,329 | +393.5% | 0.00% | +100.0% |
| Q2 2018 | $1,382,000 | +305.3% | 28,033 | +152.5% | 0.00% | – |
| Q1 2018 | $341,000 | 0.0% | 11,103 | -40.6% | 0.00% | – |
| Q4 2017 | $341,000 | – | 18,678 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |